{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:33:06Z","timestamp":1778754786485,"version":"3.51.4"},"reference-count":47,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1517\/14656566.2.11.1849","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T20:31:16Z","timestamp":1115238676000},"page":"1849-1857","source":"Crossref","is-referenced-by-count":60,"title":["Pharmacotherapy of fungal eye infections"],"prefix":"10.1517","volume":"2","author":[{"given":"Bita","family":"Manzouri","sequence":"first","affiliation":[{"name":"Moorfields Eye Hospital NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard KH","family":"Wyse","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Hammersmith Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian C","family":"Vafidis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Central Middlesex Hospital, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19136"},{"key":"e_1_2_1_6_1","unstructured":"\u2022Good concise review of anterior ocular infections."},{"key":"e_1_2_1_7_1","first-page":"111","article-title":"Fungal keratitis in a daily disposable soft contact lens wearer","volume":"27","author":"CHOI DM","year":"2001","unstructured":"CHOI DM, GOLDSTEIN MH, SALIERNO A, DRIEBE WT: Fungal keratitis in a daily disposable soft contact lens wearer. CLAO (2001) 27:111\u2013112.","journal-title":"CLAO"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"ESSMAN TF FLYNN HW Jr. SMIDDY WD et al.: Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis. Ophthalmol. Surg. Lasers (1997) 28:185\u2013194.","DOI":"10.3928\/1542-8877-19970301-03"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1159\/000310473"},{"key":"e_1_2_1_10_1","unstructured":"MCDONNELL PJ GREEN WR: Keratitis in Mandell GL Douglas RG Jr Bennett JE (Eds): Principles and Practice of Infectious Diseases. New York Churchill Livingstone (1990):981\u2013987."},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","unstructured":"O'DAY DM: New antifungal drugs in ophthalmology. Int. OphthalmoL (1996) 36(2):45\u201351.","DOI":"10.1097\/00004397-199603620-00006"},{"key":"e_1_2_1_12_1","unstructured":"WEINGEIST TA LIESEGANG TJ GILBERT GRAND M (Eds): Fungal keratitis in External Disease and Cornea. San Francisco Am. Acad. Ophthalmol. (1999)"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9394(75)90730-8"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-1313.2000.tb01121.x"},{"key":"e_1_2_1_15_1","unstructured":"\u2022\u2022Excellent review of the types of eyeinfections caused by microorganisms with classification into the various anatomical structures of the eye."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-198002030-00013"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","unstructured":"BEHRENS-BAUMANN W: Topical antimycotics in ophthalmology. Ophthalmologica (1997) 211\\(Suppl. 1):33\u201338.","DOI":"10.1159\/000310884"},{"key":"e_1_2_1_18_1","unstructured":"\u2022Good introduction to antifungal agents."},{"key":"e_1_2_1_19_1","first-page":"32","article-title":"Mycosis of the and its adenexa","author":"BEHRENS-BAUMANN W","year":"1999","unstructured":"BEHRENS-BAUMANN W: Mycosis of the and its adenexa. Dev. Ophthalmol. (1999) 32.","journal-title":"Dev. Ophthalmol."},{"key":"e_1_2_1_20_1","unstructured":"\u2022\u2022Excellent review of the ophthalmic fungalpathogens and antifungal agents."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200009000-00013"},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","unstructured":"WOOD TO WILLIFORD W: Treatment of keratomycosis with amphotericin B 0.15%. Am. J. Ophthalmol. (1976) 81(6):847\u2013849.","DOI":"10.1016\/0002-9394(76)90369-X"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713688609029240"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(88)33229-X"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.1992.tb00949.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.9.1647"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/myc.1990.33.4.203"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200011000-00019"},{"key":"e_1_2_1_29_1","unstructured":"BENNETT JE: Antimicrobial agents. In: The Pharmacological Basis of Therapeutics volume IL Goodman Gilman A Rall TW Nies AS Taylor P (Eds). Oxford Pergamon Press (1991):1165\u20131181."},{"key":"e_1_2_1_30_1","unstructured":"Heterocyclic compounds. In: Organic Chemistry volume I Finar IL (Ed). Harlow Longman Group Limited (1981)847."},{"key":"e_1_2_1_31_1","first-page":"74","article-title":"Fluconazole and itraconazole: current status and prospects for antifungal therapy","volume":"13","author":"SUGAR AM","year":"1993","unstructured":"SUGAR AM: Fluconazole and itraconazole: current status and prospects for antifungal therapy. Curr. OM. Top. Infect. Dis. (1993) 13:74\u201398.","journal-title":"Curr. OM. Top. Infect. Dis."},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2000.0936"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.10262"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198001173020304"},{"key":"e_1_2_1_35_1","first-page":"299","article-title":"Mycotic keratitis: suspectibility to antiseptic agents","volume":"19","author":"MARTIN MJ","year":"1996","unstructured":"MARTIN MJ, RAHMAN MR, JOHNSON GJ, SRINIVASAN M, CLAYTON YM: Mycotic keratitis: suspectibility to antiseptic agents. Irir Ophthalmology (1996) 19:299\u2013302.","journal-title":"Irir Ophthalmology"},{"key":"e_1_2_1_36_1","doi-asserted-by":"crossref","unstructured":"MEUNIER F: Alternative modalities of administering amphotericin B: current issues. J. Infect. (1994) 28\\(Suppl. 1):51\u201356.","DOI":"10.1016\/S0163-4453(94)95986-2"},{"key":"e_1_2_1_37_1","unstructured":"Antifungal drugs. In: British National Formulary (Volume 41) British Medical London UK (2001)."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(91)32211-5"},{"issue":"3","key":"e_1_2_1_39_1","first-page":"19","article-title":"The roleof steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis","volume":"34","author":"PINEDA R II, DOHLMAN CH","year":"1994","unstructured":"PINEDA R II, DOHLMAN CH: The roleof steroids in the management of Acanthamoeba keratitis, fungal keratitis, and epidemic keratoconjunctivitis. OM. (1994) 34(3):19\u201331.","journal-title":"OM."},{"key":"e_1_2_1_40_1","first-page":"433","article-title":"Keratomycosis: a preventable disease","volume":"78","author":"THYGESON P","year":"1974","unstructured":"THYGESON P, OKUMOTO M: Keratomycosis: a preventable disease. Trans. Am. Acad. Ophthalmol Otol. (1974) 78:433\u2013439.","journal-title":"Trans. Am. Acad. Ophthalmol Otol."},{"key":"e_1_2_1_41_1","first-page":"331","article-title":"RAY WA, ROBINSON R, STEVEN HEAD W: Efficacy of antifungal agents in the cornea: Influence of corticosteroids","volume":"25","author":"O'DAY DM","year":"1984","unstructured":"O'DAY DM, RAY WA, ROBINSON R, STEVEN HEAD W: Efficacy of antifungal agents in the cornea: Influence of corticosteroids. Invest. Ophthalmol Vis. Se (1984) 25:331\u2013335.","journal-title":"Invest. Ophthalmol Vis. Se"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","unstructured":"ANAND A MADHAVEN H NEELAM LILY T: Use of polymerase chain reaction in the diagnosis of fungal endophthalmitis. (2001) 108:326\u2013330.","DOI":"10.1016\/S0161-6420(00)00517-0"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1076\/0927-3948(200009)831-KFT189"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200007000-00031"},{"key":"e_1_2_1_45_1","unstructured":"FORSTER RK: Endophthalmitis. In: Duane Clinical Ophthalmology (CD edition). Tasman W Jaeger EA (Eds.) Lippincott Williams Wilkins Philadelphia USA (1999)."},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","unstructured":"RAHMAN MR JOHNSON GJ R HOWLADER SA MINASSIAN DC: Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br. I Ophthalmol (1998) 82:919\u2013925.","DOI":"10.1136\/bjo.82.8.919"},{"key":"e_1_2_1_47_1","unstructured":"DENTON GW: Disinfectants and antiseptics. A. By chemical type: chlorhexidine. In: Disinfection Sterilization and Preservation. (4th Edition). Block SS (Ed). Lea and Febgier Philadelphia USA (1991):274\u2013287."},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","unstructured":"VAN GOOL R: The cost of treating systemic fungal infections. Drugs (2001) 61 (Suppl. 1):49\u201356.","DOI":"10.2165\/00003495-200161001-00005"},{"key":"e_1_2_1_49_1","first-page":"181","article-title":"Prognosis of endogenous fungal endophthalmitis and utility of Ishibashi's classification","volume":"45","author":"SATO Y","year":"2001","unstructured":"SATO Y, MIYASAKA S, SHIMADA H: Prognosis of endogenous fungal endophthalmitis and utility of Ishibashi's classification. fpri. j Ophthalmol (2001) 45:181\u2013186.","journal-title":"fpri. j Ophthalmol"},{"key":"e_1_2_1_50_1","unstructured":"\u2022\u2022Excellent article for use as a basis forclinical practice in the management of fungal endophthalmitis."},{"key":"e_1_2_1_51_1","first-page":"845","article-title":"Proposed classification of of endogenous fungal","volume":"47","author":"ISHIBASHI Y","year":"1993","unstructured":"ISHIBASHI Y: Proposed classification of of endogenous fungal. fpri. I Clin. Ophthalmol (1993) 47:845\u2013849.","journal-title":"fpri. I Clin. Ophthalmol"}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.2.11.1849","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T16:55:48Z","timestamp":1769705748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.2.11.1849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1517\/14656566.2.11.1849"],"URL":"https:\/\/doi.org\/10.1517\/14656566.2.11.1849","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}